Bank Of New York Mellon Corp Bellerophon Therapeutics, Inc. Call Options Transaction History
Bank Of New York Mellon Corp
- $528 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BLPH
# of Institutions
1Shares Held
44KCall Options Held
0Put Options Held
0About Bellerophon Therapeutics, Inc.
- Ticker BLPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,545,450
- Market Cap $382K
- Description
- Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...